Deal Makers Close 2013 With String Of Big Pharma Plays
Private equity and strategic buyers alike have zeroed in on the pharmaceutical industry over the past week, capping off a busy fourth quarter with a string of big-ticket deals that formed...To view the full article, register now.
Already a subscriber? Click here to view full article